These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 24878845)

  • 1. Anti-fibrotic actions of interleukin-10 against hypertrophic scarring by activation of PI3K/AKT and STAT3 signaling pathways in scar-forming fibroblasts.
    Shi J; Li J; Guan H; Cai W; Bai X; Fang X; Hu X; Wang Y; Wang H; Zheng Z; Su L; Hu D; Zhu X
    PLoS One; 2014; 9(5):e98228. PubMed ID: 24878845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-10 alleviates lipopolysaccharide-induced skin scarring via IL-10R/STAT3 axis regulating TLR4/NF-κB pathway in dermal fibroblasts.
    Shi J; Shi S; Xie W; Zhao M; Li Y; Zhang J; Li N; Bai X; Cai W; Hu X; Hu D; Han J; Guan H
    J Cell Mol Med; 2021 Feb; 25(3):1554-1567. PubMed ID: 33410606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL10 inhibits starvation-induced autophagy in hypertrophic scar fibroblasts via cross talk between the IL10-IL10R-STAT3 and IL10-AKT-mTOR pathways.
    Shi J; Wang H; Guan H; Shi S; Li Y; Wu X; Li N; Yang C; Bai X; Cai W; Yang F; Wang X; Su L; Zheng Z; Hu D
    Cell Death Dis; 2016 Mar; 7(3):e2133. PubMed ID: 26962683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Pathological Phenotype of Hypertrophic Scar Fibroblasts Via Coculture with Adipose-Derived Stem Cells.
    Deng J; Shi Y; Gao Z; Zhang W; Wu X; Cao W; Liu W
    Tissue Eng Part A; 2018 Mar; 24(5-6):382-393. PubMed ID: 28562226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-143-3p inhibits hyperplastic scar formation by targeting connective tissue growth factor CTGF/CCN2 via the Akt/mTOR pathway.
    Mu S; Kang B; Zeng W; Sun Y; Yang F
    Mol Cell Biochem; 2016 May; 416(1-2):99-108. PubMed ID: 27075467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centella triterpenes cream as a potential drug for the treatment of hypertrophic scar through inhibiting the phosphorylation of STAT3: A network pharmacology analysis and in vitro experiments.
    Tan M; Wu D; Zhou Y; Duan B
    J Cosmet Dermatol; 2023 Dec; 22(12):3511-3519. PubMed ID: 37563868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis.
    Li Y; Zhang J; Shi J; Liu K; Wang X; Jia Y; He T; Shen K; Wang Y; Liu J; Zhang W; Wang H; Zheng Z; Hu D
    Stem Cell Res Ther; 2021 Mar; 12(1):221. PubMed ID: 33789737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin inhibits fibroblast cell functions and hypertrophic scar formation by enhancing autophagy through the MT2 receptor-inhibited PI3K/Akt /mTOR signaling.
    Dong Y; Cao X; Huang J; Hu Z; Chen C; Chen M; Long Q; Xu Z; Lv D; Rong Y; Luo S; Wang H; Deng W; Tang B
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166887. PubMed ID: 37739092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IL-6 trans-signaling-STAT3 pathway mediates ECM and cellular proliferation in fibroblasts from hypertrophic scar.
    Ray S; Ju X; Sun H; Finnerty CC; Herndon DN; Brasier AR
    J Invest Dermatol; 2013 May; 133(5):1212-20. PubMed ID: 23303450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptotanshinone downregulates the profibrotic activities of hypertrophic scar fibroblasts and accelerates wound healing: A potential therapy for the reduction of skin scarring.
    Li Y; Shi S; Gao J; Han S; Wu X; Jia Y; Su L; Shi J; Hu D
    Biomed Pharmacother; 2016 May; 80():80-86. PubMed ID: 27133042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of ANGPT2 activates autophagy during hypertrophic scar formation via PI3K/AKT/mTOR pathway.
    Chen H; Xu K; Sun C; Gui S; Wu J; Wang S
    An Bras Dermatol; 2023; 98(1):26-35. PubMed ID: 36272879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT
    Chaturvedi S; Misra DP; Prasad N; Rastogi K; Singh H; Rai MK; Agarwal V
    Int J Rheum Dis; 2018 Dec; 21(12):2128-2138. PubMed ID: 30207074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-fibrotic effect of IL-6 via aortic adventitial fibroblasts indicates IL-6 as a treatment target in Takayasu arteritis.
    Kong X; Ma L; Ji Z; Dong Z; Zhang Z; Hou J; Zhang S; Ma L; Jiang L
    Clin Exp Rheumatol; 2018; 36(1):62-72. PubMed ID: 28770707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II regulates phosphoinositide 3 kinase/Akt cascade via a negative crosstalk between AT1 and AT2 receptors in skin fibroblasts of human hypertrophic scars.
    Liu HW; Cheng B; Yu WL; Sun RX; Zeng D; Wang J; Liao YX; Fu XB
    Life Sci; 2006 Jun; 79(5):475-83. PubMed ID: 16522324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panax Notoginseng Saponins suppresses TRPM7 via the PI3K/AKT pathway to inhibit hypertrophic scar formation in vitro.
    Zhi Y; Wang H; Huang B; Yan G; Yan LZ; Zhang W; Zhang J
    Burns; 2021 Jun; 47(4):894-905. PubMed ID: 33143990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of TGF-β peptide antagonist on the fibrotic phenotype of human hypertrophic scar fibroblasts.
    Wang X; Gao Z; Wu X; Zhang W; Zhou G; Liu W
    Pharm Biol; 2016 Jul; 54(7):1189-97. PubMed ID: 26135051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corilagin alleviates hypertrophic scars via inhibiting the transforming growth factor (TGF)-β/Smad signal pathway.
    Li Y; Yu Z; Zhao D; Han D
    Life Sci; 2021 Jul; 277():119483. PubMed ID: 33862115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microfat exerts an anti-fibrotic effect on human hypertrophic scar via fetuin-A/ETV4 axis.
    Yu Q; Dai Q; Huang Z; Li C; Yan L; Fu X; Wang Q; Zhang Y; Cai L; Yang Z; Xiao R
    J Transl Med; 2023 Mar; 21(1):231. PubMed ID: 37004048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against TGF-β1-induced fibrosis effects of IL-10 on dermal fibroblasts and its potential therapeutics for the reduction of skin scarring.
    Shi JH; Guan H; Shi S; Cai WX; Bai XZ; Hu XL; Fang XB; Liu JQ; Tao K; Zhu XX; Tang CW; Hu DH
    Arch Dermatol Res; 2013 May; 305(4):341-52. PubMed ID: 23321694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ellagic acid inhibits the formation of hypertrophic scars by suppressing TGF-β/Smad signaling pathway activity.
    Zhao ZJ; Wu DJ; Lv DL; Zhang BD; Chen L; Sun YQ
    Chem Biol Drug Des; 2023 Oct; 102(4):773-781. PubMed ID: 37386691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.